Back to Search
Start Over
Multifunctional Probiotic and Functional Properties of Lactiplantibacillus plantarum LRCC5314, Isolated from Kimchi
- Source :
- Journal of Microbiology and Biotechnology. 32:72-80
- Publication Year :
- 2022
- Publisher :
- Journal of Microbiology and Biotechnology, 2022.
-
Abstract
- In this study, the survival capacity (acid and bile salt tolerance, and adhesion to gut epithelial cells) and probiotic properties (enzyme activity-inhibition and anti-inflammatory activities, inhibition of adipogenesis, and stress hormone level reduction) of Lactiplantibacillus plantarum LRCC5314, isolated from kimchi (Korean traditional fermented cabbage), were investigated. LRCC5314 exhibited very stable survival at pH 2 and in 0.2% bile acid with 89.9% adhesion to Caco-2 intestinal epithelial cells after treatment for 2 h. LRCC5314 also inhibited the activities of α-amylase and α-glucosidase, which are involved in elevating postprandial blood glucose levels, by approximately 72.9% and 51.2%, respectively. Treatment of lipopolysaccharide (LPS)-stimulated RAW 264.7 cells with the LRCC5314 lysate decreased the levels of the inflammatory factors nitric oxide, tumor necrosis factor (TNF-α), interleukin (IL)-1β, and interferon-γ by 88.5%, 49.3%, 97.2%, and 99.8%, respectively, relative to those of the cells treated with LPS alone. LRCC5314 also inhibited adipogenesis in differentiating preadipocytes (3T3-L1 cells), showing a 14.7% decrease in lipid droplet levels and a 74.0% decrease in triglyceride levels, as well as distinct reductions in the mRNA expression levels of adiponectin, FAS, PPAR, C/EBPα, TNF-α, and IL-6. Moreover, LRCC5314 reduced the level of cortisol, a hormone with important effect on stress, by approximately 35.6% in H295R cells. L. plantarum LRCC5314 is identified as a new probiotic with excellent in vitro multifunctional properties. Subsequent in vivo studies may further demonstrate its potential as a functional food or pharmabiotic.
- Subjects :
- medicine.medical_specialty
Bile acid
Lipopolysaccharide
medicine.drug_class
Interleukin
General Medicine
Applied Microbiology and Biotechnology
Nitric oxide
law.invention
chemistry.chemical_compound
Probiotic
Endocrinology
chemistry
In vivo
law
Adipogenesis
Internal medicine
medicine
Tumor necrosis factor alpha
Biotechnology
Subjects
Details
- ISSN :
- 17388872 and 10177825
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Journal of Microbiology and Biotechnology
- Accession number :
- edsair.doi...........eada610ef20ff215489e7c9603294916
- Full Text :
- https://doi.org/10.4014/jmb.2109.09025